PRTK Annual CFI
$14.80 M
+$10.29 M+228.25%
31 December 2022
Summary:
As of January 21, 2025, PRTK annual cash flow from investing activities is $14.80 million, with the most recent change of +$10.29 million (+228.25%) on December 31, 2022. During the last 3 years, it has fallen by -$119.75 million (-89.00%).PRTK Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Quarterly CFI
$0.00
+$32.00 K+100.00%
30 June 2023
Summary:
As of January 21, 2025, PRTK quarterly cash flow from investing activities is $0.00, with the most recent change of +$32.00 thousand (+100.00%) on June 30, 2023. Over the past year, it has stayed the same.PRTK Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK TTM CFI
$29.97 M
$0.000.00%
30 June 2023
Summary:
As of January 21, 2025, PRTK TTM cash flow from investing activities is $29.97 million, unchanged on June 30, 2023. Over the past year, it has increased by +$60.27 million (+198.88%).PRTK TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PRTK Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +228.3% | 0.0% | +198.9% |
| 3 y3 years | -89.0% | -100.0% | -61.8% |
| 5 y5 years | +134.7% | +100.0% | -77.7% |
PRTK Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -89.0% | -100.0% | -79.3% |
Paratek Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $0.00(-100.0%) | $29.97 M(0.0%) |
| Mar 2023 | - | -$32.00 K(-100.1%) | $29.97 M(+102.4%) |
| Dec 2022 | $14.80 M(+228.2%) | $30.00 M(>+9900.0%) | $14.80 M(-148.8%) |
| Sept 2022 | - | $0.00(0.0%) | -$30.31 M(+0.0%) |
| June 2022 | - | $0.00(-100.0%) | -$30.31 M(-0.4%) |
| Mar 2022 | - | -$15.20 M(+0.5%) | -$30.42 M(-774.6%) |
| Dec 2021 | $4.51 M(-95.1%) | -$15.12 M(<-9900.0%) | $4.51 M(-90.3%) |
| Sept 2021 | - | $6000.00(-105.1%) | $46.58 M(+5.8%) |
| June 2021 | - | -$117.00 K(-100.6%) | $44.04 M(-36.3%) |
| Mar 2021 | - | $19.74 M(-26.8%) | $69.12 M(-25.3%) |
| Dec 2020 | $92.50 M(-31.3%) | $26.95 M(-1163.7%) | $92.50 M(+26.3%) |
| Sept 2020 | - | -$2.53 M(-110.2%) | $73.22 M(-6.7%) |
| June 2020 | - | $24.96 M(-42.1%) | $78.45 M(-27.1%) |
| Mar 2020 | - | $43.12 M(+461.7%) | $107.68 M(-20.0%) |
| Dec 2019 | $134.55 M(-205.2%) | $7.68 M(+184.4%) | $134.55 M(+29.7%) |
| Sept 2019 | - | $2.70 M(-95.0%) | $103.73 M(-28.4%) |
| June 2019 | - | $54.19 M(-22.6%) | $144.79 M(-469.7%) |
| Mar 2019 | - | $69.99 M(-402.4%) | -$39.17 M(-69.4%) |
| Dec 2018 | -$127.87 M(+199.8%) | -$23.15 M(-152.9%) | -$127.87 M(+41.1%) |
| Sept 2018 | - | $43.76 M(-133.7%) | -$90.61 M(-35.8%) |
| June 2018 | - | -$129.77 M(+593.4%) | -$141.13 M(+144.1%) |
| Mar 2018 | - | -$18.72 M(-232.6%) | -$57.81 M(+35.5%) |
| Dec 2017 | -$42.66 M(-42.9%) | $14.11 M(-308.9%) | -$42.66 M(-30.9%) |
| Sept 2017 | - | -$6.76 M(-85.5%) | -$61.73 M(+2.7%) |
| June 2017 | - | -$46.45 M(+1204.1%) | -$60.08 M(+573.6%) |
| Mar 2017 | - | -$3.56 M(-28.2%) | -$8.92 M(-88.1%) |
| Dec 2016 | -$74.76 M(>+9900.0%) | -$4.96 M(-2.8%) | -$74.76 M(+6.9%) |
| Sept 2016 | - | -$5.11 M(-208.4%) | -$69.92 M(+8.0%) |
| June 2016 | - | $4.71 M(-106.8%) | -$64.73 M(-7.5%) |
| Mar 2016 | - | -$69.40 M(>+9900.0%) | -$69.95 M(>+9900.0%) |
| Dec 2015 | -$603.00 K(-104.4%) | -$128.00 K(-245.5%) | -$603.00 K(-97.7%) |
| Sept 2015 | - | $88.00 K(-117.3%) | -$26.58 M(+30.5%) |
| June 2015 | - | -$509.00 K(+842.6%) | -$20.37 M(-1090.1%) |
| Mar 2015 | - | -$54.00 K(-99.8%) | $2.06 M(-84.9%) |
| Dec 2014 | $13.67 M | -$26.11 M(-514.1%) | $13.67 M(-67.1%) |
| Sept 2014 | - | $6.30 M(-71.2%) | $41.53 M(+27.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2014 | - | $21.91 M(+89.6%) | $32.60 M(+1453.3%) |
| Mar 2014 | - | $11.56 M(+559.6%) | $2.10 M(-113.9%) |
| Dec 2013 | -$15.06 M(-391.3%) | $1.75 M(-166.9%) | -$15.06 M(-55.9%) |
| Sept 2013 | - | -$2.62 M(-69.5%) | -$34.19 M(+100.0%) |
| June 2013 | - | -$8.59 M(+53.3%) | -$17.09 M(-442.6%) |
| Mar 2013 | - | -$5.60 M(-67.7%) | $4.99 M(-3.5%) |
| Dec 2012 | $5.17 M(+308.4%) | -$17.38 M(-220.0%) | $5.17 M(-74.9%) |
| Sept 2012 | - | $14.48 M(+7.3%) | $20.63 M(+94.8%) |
| June 2012 | - | $13.49 M(-348.8%) | $10.59 M(+527.5%) |
| Mar 2012 | - | -$5.42 M(+183.0%) | $1.69 M(+33.3%) |
| Dec 2011 | $1.27 M(-92.1%) | -$1.92 M(-143.1%) | $1.27 M(-87.3%) |
| Sept 2011 | - | $4.44 M(-3.1%) | $10.01 M(-20.3%) |
| June 2011 | - | $4.58 M(-178.5%) | $12.55 M(-25.4%) |
| Mar 2011 | - | -$5.84 M(-185.7%) | $16.83 M(+4.7%) |
| Dec 2010 | $16.07 M(+9.7%) | $6.82 M(-2.4%) | $16.07 M(-15.8%) |
| Sept 2010 | - | $6.99 M(-21.1%) | $19.09 M(-360.3%) |
| June 2010 | - | $8.86 M(-234.2%) | -$7.33 M(-78.4%) |
| Mar 2010 | - | -$6.61 M(-167.1%) | -$33.91 M(-331.4%) |
| Dec 2009 | $14.65 M(-34.7%) | $9.84 M(-150.6%) | $14.65 M(-62.4%) |
| Sept 2009 | - | -$19.43 M(+9.7%) | $38.94 M(-25.6%) |
| June 2009 | - | -$17.71 M(-142.2%) | $52.34 M(-26.9%) |
| Mar 2009 | - | $41.95 M(+22.9%) | $71.63 M(+219.3%) |
| Dec 2008 | $22.44 M(-221.3%) | $34.13 M(-666.7%) | $22.44 M(+229.2%) |
| Sept 2008 | - | -$6.02 M(-481.4%) | $6.82 M(-116.5%) |
| June 2008 | - | $1.58 M(-121.8%) | -$41.40 M(+7.9%) |
| Mar 2008 | - | -$7.24 M(-139.2%) | -$38.37 M(+107.4%) |
| Dec 2007 | -$18.50 M(-48.1%) | $18.50 M(-134.1%) | -$18.50 M(-65.7%) |
| Sept 2007 | - | -$54.23 M(-1276.9%) | -$53.92 M(-920.9%) |
| June 2007 | - | $4.61 M(-63.5%) | $6.57 M(-148.8%) |
| Mar 2007 | - | $12.63 M(-174.6%) | -$13.46 M(-62.2%) |
| Dec 2006 | -$35.63 M(-249.1%) | -$16.93 M(-370.3%) | -$35.63 M(+90.5%) |
| Sept 2006 | - | $6.26 M(-140.6%) | -$18.70 M(-25.1%) |
| June 2006 | - | -$15.42 M(+61.6%) | -$24.97 M(+161.6%) |
| Mar 2006 | - | -$9.54 M | -$9.54 M |
| Dec 2005 | $23.90 M(+2200.6%) | - | - |
| Dec 2004 | $1.04 M | - | - |
FAQ
- What is Paratek Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals annual CFI year-on-year change?
- What is Paratek Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals quarterly CFI year-on-year change?
- What is Paratek Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Paratek Pharmaceuticals?
- What is Paratek Pharmaceuticals TTM CFI year-on-year change?
What is Paratek Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of PRTK is $14.80 M
What is the all time high annual CFI for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high annual cash flow from investing activities is $134.55 M
What is Paratek Pharmaceuticals annual CFI year-on-year change?
Over the past year, PRTK annual cash flow from investing activities has changed by +$10.29 M (+228.25%)
What is Paratek Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of PRTK is $0.00
What is the all time high quarterly CFI for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high quarterly cash flow from investing activities is $69.99 M
What is Paratek Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, PRTK quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Paratek Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of PRTK is $29.97 M
What is the all time high TTM CFI for Paratek Pharmaceuticals?
Paratek Pharmaceuticals all-time high TTM cash flow from investing activities is $144.79 M
What is Paratek Pharmaceuticals TTM CFI year-on-year change?
Over the past year, PRTK TTM cash flow from investing activities has changed by +$60.27 M (+198.88%)